[HTML][HTML] Gallbladder cancer: current multimodality treatment concepts and future directions
N Sturm, JS Schuhbaur, F Hüttner, L Perkhofer… - Cancers, 2022 - mdpi.com
Simple Summary Gallbladder cancer is the most common malignancy of the biliary tract and
is associated with several risk factors such as female sex, ethnic background, and chronic …
is associated with several risk factors such as female sex, ethnic background, and chronic …
[HTML][HTML] Intrahepatic cholangiocarcinoma: tumour heterogeneity and its clinical relevance
M Komuta - Clinical and molecular hepatology, 2022 - ncbi.nlm.nih.gov
Abstract Treatment of intrahepatic cholangiocarcinoma (iCCA) is currently at a significant
turning point due to the identification of isocitrate dehydrogenase (IDH) mutations and …
turning point due to the identification of isocitrate dehydrogenase (IDH) mutations and …
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules
and the second-order bile ducts. It is the second most frequent primary liver cancer after …
and the second-order bile ducts. It is the second most frequent primary liver cancer after …
Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a …
D Albers, A Schmidt, M Schiemer, K Caca… - Gastrointestinal …, 2022 - Elsevier
Background and Aims Endobiliary radiofrequency ablation (RFA), usually combined with
endoscopic stent insertion, is a simple procedure with the potential to improve stent patency …
endoscopic stent insertion, is a simple procedure with the potential to improve stent patency …
Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study
Background The aim of this study was to investigate the prognostic impact of perineural
invasion (PNI) on tumour recurrence and survival among patients with resected intrahepatic …
invasion (PNI) on tumour recurrence and survival among patients with resected intrahepatic …
[PDF][PDF] 欧洲肝脏研究协会及国际肝癌协会2023 版《 肝内胆管癌治疗临床实践指南》 更新解读
覃德龙， 陈家璐， 唐玥， 汤朝晖， 全志伟 - 中国普通外科杂志, 2023 - zpwz.net
摘要欧洲肝脏研究协会(EASL) 及国际肝癌协会(ILCA) 于2023 年发布最新的《
肝内胆管癌治疗临床实践指南》(简称新版指南). 相较于EASL-ILCA 在2014 …
肝内胆管癌治疗临床实践指南》(简称新版指南). 相较于EASL-ILCA 在2014 …
Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
MC Bragazzi, R Venere, E Ribichini, F Covotta… - Digestive and Liver …, 2023 - Elsevier
Intrahepatic cholangiocarcinoma is the second most frequent primary liver cancer after
hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …
hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …
How to determine unresectability in hilar cholangiocarcinoma
Background Cholangiocarcinoma (CCA) is a cancer arising from the biliary epithelium and
represents the second most common primary liver tumor following hepatocellular carcinoma …
represents the second most common primary liver tumor following hepatocellular carcinoma …
[HTML][HTML] Contrast-enhanced imaging in the management of intrahepatic cholangiocarcinoma: state of art and future perspectives
Simple Summary Contrast imaging techniques play a pivotal role in the diagnosis and
management of Intrahepatic cholangiocarcinoma (iCCA). There is an increasing interest in …
management of Intrahepatic cholangiocarcinoma (iCCA). There is an increasing interest in …
[HTML][HTML] Non-coding RNA and Drug resistance in cholangiocarcinoma
Z Wu, S Jiang, Y Chen - Non-coding RNA Research, 2023 - Elsevier
Cholangiocarcinoma is a highly aggressive cancer with a dismal prognosis and limited
resectability. Chemotherapy has demonstrated tremendous benefits for patients with …
resectability. Chemotherapy has demonstrated tremendous benefits for patients with …